TRANSFIX Zenith® Transection Clinical Study

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 23, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 29, 2019

Conditions
Thoracic AortaThoracic InjuriesBlunt Injuries
Interventions
DEVICE

Zenith® TX2® Low Profile Endovascular Graft

Treatment of Blunt thoracic aortic injuries (BTAIs)

Trial Locations (21)

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

21201

University of Maryland Medical Center, Baltimore

22908

University of Virginia Medical Center, Charlottesville

27599

University of North Carolina Vascular Surgery, Chapel Hill

30303

Grady Memorial Hospital, Atlanta

33136

University of Miami School of Medicine, Miami

37920

University of Tennessee Medical School, Knoxville

39216

University of Mississippi Medical Center, Jackson

40292

University of Louisville, Louisville

45267

University of Cincinnati University Hospital, Cincinnati

63141

Mercy Hospital St. Louis, St Louis

72205

University of Arkansas for Medical Sciences, Little Rock

75235

UT Southwestern Medical Center - Parkland Memorial Hospital, Dallas

90033

Keck Hospital of USC, Los Angeles

90048

Cedars-Sinai Medical Center, Los Angeles

98104

University of Washington - Harborview Medical Center, Seattle

08103

Cooper University Hospital, Camden

07601

Hackensack University Medical Center, Hackensack

07103

Rutgers University, Newark

02903

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY

NCT01688050 - TRANSFIX Zenith® Transection Clinical Study | Biotech Hunter | Biotech Hunter